- Stocks
- Healthcare
- NASDAQ: NTRA

Price (delayed)

$85.28

Market cap

$10.3B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.78

Enterprise value

$10.09B

Naterais a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a

Natera's gross profit has increased by 35% YoY and by 17% QoQ

NTRA's revenue is up by 32% year-on-year and by 9% since the previous quarter

The quick ratio has declined by 8% since the previous quarter but it has increased by 2.4% year-on-year

NTRA's equity is up by 8% year-on-year but it is down by 2.5% since the previous quarter

What are the main financial stats of NTRA

Market
Valuations
Earnings

Shares outstanding

120.76M

Market cap

$10.3B

Enterprise value

$10.09B

Price to earnings (P/E)

N/A

Price to book (P/B)

13.39

Price to sales (P/S)

9.06

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

9.32

Revenue

$1.08B

EBIT

-$421.89M

EBITDA

-$383.28M

Free cash flow

-$286.15M

Per share
Balance sheet
Liquidity

EPS

-$3.78

Free cash flow per share

-$2.49

Book value per share

$6.37

Revenue per share

$9.41

TBVPS

$12.54

Total assets

$1.44B

Total liabilities

$676.37M

Debt

$430.37M

Equity

$765.33M

Working capital

$951.28M

Debt to equity

0.56

Current ratio

4.1

Quick ratio

3.77

Net debt/EBITDA

0.55

Margins
Efficiency
Dividend

EBITDA margin

-35.4%

Gross margin

45.5%

Net margin

-40.2%

Operating margin

-41.2%

Return on assets

-31.9%

Return on equity

-62.2%

Return on invested capital

-43%

Return on capital employed

-37.2%

Return on sales

-39%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Natera stock price performed over time

Intraday

-2.29%

1 week

-9.73%

1 month

-6.55%

1 year

60.51%

YTD

36.14%

QTD

-6.76%

How have Natera's revenue and profit performed over time

Revenue

$1.08B

Gross profit

$492.74M

Operating income

-$446.25M

Net income

-$434.8M

Gross margin

45.5%

Net margin

-40.2%

The company's net margin rose by 40% YoY and by 20% QoQ

NTRA's operating margin is up by 38% year-on-year and by 19% since the previous quarter

Natera's gross profit has increased by 35% YoY and by 17% QoQ

NTRA's revenue is up by 32% year-on-year and by 9% since the previous quarter

What is Natera's growth rate over time

What is Natera stock price valuation

P/E

N/A

P/B

13.39

P/S

9.06

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

9.32

The EPS has increased by 32% YoY and by 16% from the previous quarter

The stock's P/B is 52% more than its last 4 quarters average of 8.8

NTRA's equity is up by 8% year-on-year but it is down by 2.5% since the previous quarter

NTRA's price to sales (P/S) is 46% higher than its last 4 quarters average of 6.2 but 12% lower than its 5-year quarterly average of 10.3

NTRA's revenue is up by 32% year-on-year and by 9% since the previous quarter

How efficient is Natera business performance

The ROE has grown by 42% YoY and by 15% from the previous quarter

The ROS has increased by 40% YoY and by 21% from the previous quarter

The ROA is up by 33% year-on-year and by 14% since the previous quarter

The return on invested capital has increased by 12% year-on-year and by 10% since the previous quarter

What is NTRA's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for NTRA.

How did Natera financials performed over time

NTRA's total assets is 113% higher than its total liabilities

The quick ratio has declined by 8% since the previous quarter but it has increased by 2.4% year-on-year

The current ratio is down by 6% since the previous quarter but it is up by 5% year-on-year

The company's debt is 44% lower than its equity

The debt to equity has contracted by 10% YoY

NTRA's equity is up by 8% year-on-year but it is down by 2.5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.